Literature DB >> 16361283

Cryptorchidism in LhrKO animals and the effect of testosterone-replacement therapy.

F P Yuan1, D X Lin, C V Rao, Z M Lei.   

Abstract

BACKGROUND: The objective of the current study was to characterize the morphological and genetic basis of cryptorchidism. METHODS AND
RESULTS: We investigated cryptorchidism in LH receptor (Lhr) knockout (LhrKO) mice and how testosterone-replacement therapy (TRT) worked to correct the phenotype. The results revealed that while gubernacular development was indistinguishable between Lhr-null and wild-type animals until 7 days of age, it was subsequently severely impaired in null animals. This was due to a reduction in mesenchymal cell division, differentiation into cremaster muscle cells and their delayed maturation. While transcript levels of Hoxa10, Hoxa11, Desrt and Dll1 were indistinguishable, the levels of Notch1, Numb and Lgr8 in the gubernaculum and Insl3 in the testes were lower in Lhr-null than in wild-type siblings. The TRT, which completed testicular descent into the scrotum, corrected the morphological changes and the expression of Lgr8, Numb and Notch, but not Insl3, to wild-type levels. Transection of the genitofemoral nerve did not prevent the TRT effect.
CONCLUSION: In summary, cryptorchidism in Lhr-null animals was caused by defects in the gubernacular development due to testosterone deficiency. TRT reversed all the morphological and gene expression changes except Insl3, suggesting that testosterone, not INSL3, secreted by Leydig cells, facilitates the completion of testicular descent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361283     DOI: 10.1093/humrep/dei433

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Re: Regulation of testicular descent.

Authors:  F Hadziselimovic
Journal:  Pediatr Surg Int       Date:  2015-05-13       Impact factor: 1.827

2.  Expression of genomic functional estrogen receptor 1 in mouse sertoli cells.

Authors:  Jing Lin; Jia Zhu; Xian Li; Shengqiang Li; Zijian Lan; Jay Ko; Zhenmin Lei
Journal:  Reprod Sci       Date:  2014-03-10       Impact factor: 3.060

3.  Luteinizing hormone receptor deficiency increases the susceptibility to alkylating agent-induced lymphomagenesis in mice.

Authors:  Yinghao Yu; Fangping Yuan; Xian Li; Dexin Lin; Zijian Lan; C V Rao; Zhenmin Lei
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

4.  The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice.

Authors:  F P Yuan; X Li; J Lin; C Schwabe; E E Büllesbach; C V Rao; Z M Lei
Journal:  Reproduction       Date:  2010-02-12       Impact factor: 3.906

Review 5.  A novel role for CFTR interaction with LH and FGF in azoospermia and epididymal maldevelopment caused by cryptorchidism.

Authors:  Faruk Hadziselimovic; Gilvydas Verkauskas; Michael Stadler
Journal:  Basic Clin Androl       Date:  2022-06-21

Review 6.  Involvement of Fibroblast Growth Factors and Their Receptors in Epididymo-Testicular Descent and Maldescent.

Authors:  Faruk Hadziselimovic
Journal:  Mol Syndromol       Date:  2016-02-02

Review 7.  On the descent of the epididymo-testicular unit, cryptorchidism, and prevention of infertility.

Authors:  Faruk Hadziselimovic
Journal:  Basic Clin Androl       Date:  2017-11-14

8.  Nuclear and Membrane Receptors for Sex Steroids Are Involved in the Regulation of Delta/Serrate/LAG-2 Proteins in Rodent Sertoli Cells.

Authors:  Sylwia Lustofin; Alicja Kamińska; Małgorzata Brzoskwinia; Joanna Cyran; Małgorzata Kotula-Balak; Barbara Bilińska; Anna Hejmej
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

9.  Adipose-derived cells improve left ventricular diastolic function and increase microvascular perfusion in advanced age.

Authors:  Natia Q Kelm; Jason E Beare; Fangping Yuan; Monika George; Charles M Shofner; Bradley B Keller; James B Hoying; Amanda J LeBlanc
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.